1-167117353-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001080426.3(STYXL2):c.231A>T(p.Ala77Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00102 in 1,610,884 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0054 ( 10 hom., cov: 32)
Exomes 𝑓: 0.00056 ( 6 hom. )
Consequence
STYXL2
NM_001080426.3 synonymous
NM_001080426.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.468
Genes affected
STYXL2 (HGNC:25034): (serine/threonine/tyrosine interacting like 2) Predicted to enable protein tyrosine/serine/threonine phosphatase activity. Predicted to be involved in protein dephosphorylation. Predicted to be located in sarcomere. [provided by Alliance of Genome Resources, Apr 2022]
GPA33 (HGNC:4445): (glycoprotein A33) The glycoprotein encoded by this gene is a cell surface antigen that is expressed in greater than 95% of human colon cancers. The open reading frame encodes a 319-amino acid polypeptide having a putative secretory signal sequence and 3 potential glycosylation sites. The predicted mature protein has a 213-amino acid extracellular region, a single transmembrane domain, and a 62-amino acid intracellular tail. The sequence of the extracellular region contains 2 domains characteristic of the CD2 subgroup of the immunoglobulin (Ig) superfamily. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 1-167117353-A-T is Benign according to our data. Variant chr1-167117353-A-T is described in ClinVar as [Benign]. Clinvar id is 715851.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.468 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00541 (824/152332) while in subpopulation AFR AF= 0.019 (789/41574). AF 95% confidence interval is 0.0179. There are 10 homozygotes in gnomad4. There are 387 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 10 gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STYXL2 | ENST00000361200.7 | c.231A>T | p.Ala77Ala | synonymous_variant | 4/6 | 5 | NM_001080426.3 | ENSP00000354483.2 | ||
STYXL2 | ENST00000271385.9 | c.231A>T | p.Ala77Ala | synonymous_variant | 4/6 | 1 | ENSP00000271385.5 | |||
STYXL2 | ENST00000443333.1 | c.231A>T | p.Ala77Ala | synonymous_variant | 3/5 | 5 | ENSP00000404874.1 | |||
GPA33 | ENST00000632571.1 | c.-281-43814T>A | intron_variant | 4 | ENSP00000488407.1 |
Frequencies
GnomAD3 genomes AF: 0.00540 AC: 822AN: 152214Hom.: 10 Cov.: 32
GnomAD3 genomes
AF:
AC:
822
AN:
152214
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00141 AC: 345AN: 244272Hom.: 4 AF XY: 0.00105 AC XY: 139AN XY: 131928
GnomAD3 exomes
AF:
AC:
345
AN:
244272
Hom.:
AF XY:
AC XY:
139
AN XY:
131928
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000564 AC: 823AN: 1458552Hom.: 6 Cov.: 31 AF XY: 0.000467 AC XY: 339AN XY: 725190
GnomAD4 exome
AF:
AC:
823
AN:
1458552
Hom.:
Cov.:
31
AF XY:
AC XY:
339
AN XY:
725190
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00541 AC: 824AN: 152332Hom.: 10 Cov.: 32 AF XY: 0.00520 AC XY: 387AN XY: 74486
GnomAD4 genome
AF:
AC:
824
AN:
152332
Hom.:
Cov.:
32
AF XY:
AC XY:
387
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 30, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at